Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |